$$1bn dollar contract with $96 bn pharma, page-31

BD it is a supply agreement but without any committed demand from Sanofi. The 150m is meaningless to us shareholders. All we know is that one day Sanofi could order anywhere between 1 and 450m syringes. How on earth can UNS plan anything on this. They must have an idea of annual demand. This needs to be relayed. As for the revenue guidance, that is but a dream. If the conference call doesn't have more info, this deal can be filed with the others.